CIK 0001650648 · Non-accelerated filer<br>Smaller reporting company
4D Molecular Therapeutics, Inc.
Sign in to watch- Ticker
- FDMT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473506994
- Phone
- 5105052680
- Business address
- 5858 HORTON STREET #455, EMERYVILLE, CA, 94608
- Former names
- 4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,724,648
- in 7 filings, $2.7M under 10b5-1 plans
Net −$2,724,648. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-11 | Bizily Scott Chief Legal and HR Officer | Grant or award · Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2023-12-11 | Kim Robert Young Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2023-12-11 | Kirn David Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +590,000 | 590,000 | ||
| 2023-12-11 | Kamal Fariborz President and COO | Grant or award · Stock Option (Right to Buy) | +260,000 | 260,000 | ||
| 2023-10-01 | Mehra Uneek See Remarks | Grant or award · Stock Option (Right to Buy) | +229,634 | 229,634 | ||
| 2023-06-08 | Bizily Scott Chief Legal and HR Officer | Option exercise | +3,750 | $8.04 | $30K | 5,487 |
| 2023-06-08 | Bizily Scott Chief Legal and HR Officer | Sale | −3,750 | $20.85 | $78K | 1,737 |
| 2023-06-08 | Bizily Scott Chief Legal and HR Officer | Option exercise · Stock Option (Right to Buy) | −3,750 | 48,750 | ||
| 2023-06-01 | Bizily Scott Chief Legal and HR Officer | Option exercise | +1,875 | $6.49 | $12K | 3,984 |
| 2023-06-01 | Bizily Scott Chief Legal and HR Officer | Sale | −2,247 | $18.31 | $41K | 1,737 |
| 2023-06-01 | Bizily Scott Chief Legal and HR Officer | Option exercise · Stock Option (Right to Buy) | −1,875 | 18,375 | ||
| 2023-05-23 | MILLIGAN JOHN F Director | Grant or award · Stock Option (Right to Buy) | +33,750 | 33,750 | ||
| 2023-05-23 | Tomasello Shawn Director | Grant or award · Stock Option (Right to Buy) | +22,500 | 22,500 | ||
| 2023-05-23 | Miller-Rich Nancy Director | Grant or award · Stock Option (Right to Buy) | +22,500 | 22,500 | ||
| 2023-05-23 | THEUER CHARLES Director | Grant or award · Stock Option (Right to Buy) | +22,500 | 22,500 | ||
| 2023-05-23 | GRAY SUSANNAH Director | Grant or award · Stock Option (Right to Buy) | +22,500 | 22,500 | ||
| 2023-05-23 | Chacko Jacob Director | Grant or award · Stock Option (Right to Buy) | +22,500 | 22,500 | ||
| 2023-05-23 | Kasahara Noriyuki Director | Grant or award · Stock Option (Right to Buy) | +22,500 | 22,500 | ||
| 2023-05-15 | Moretti August J Chief Financial Officer | Option exercise | +3,000 | $9.41 | $28K | 11,045 |
| 2023-05-15 | Moretti August J Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −3,000 | 217,060 |
Page 11 of 16 · 319 trades